Lv51
920 积分 2024-05-14 加入
A NEW SERUM TYPE SYSTEM IN MAN—THE Lp SYSTEM
1小时前
待确认
Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a)
2天前
已完结
Olpasiran, Oxidized Phospholipids, and Systemic Inflammatory Biomarkers
2天前
已完结
Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a)
17天前
已完结
Lipoprotein(a), platelet function and cardiovascular disease
2个月前
已完结
Effect of PCSK9 inhibitors on major cardiac adverse events and lipoprotein-a in patients with coronary heart disease: a meta-analysis
3个月前
已关闭
Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above
3个月前
已关闭
Strike early–strike strong lipid-lowering strategy with proprotein convertase subtilisin/kexin type 9 inhibitors in acute coronary syndrome patients: real-world evidence from the AT-TARGET-IT registry
3个月前
已完结
Oral Muvalaplin for Lowering of Lipoprotein(a)
3个月前
已完结
Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study
4个月前
已完结
皖公网安备34019202002308
